Quick-dispersing oral drug delivery systems

Drug Delivery to the Oral Cavity: Molecules to Market

Volumn , Issue , 2005, Pages 261-290

  Sharma, Kuldeepak ^a   Pfister, William R ^b   Ghosh, Tapash K ^c  

^a NexMed Inc ^*  (United States)

^b NexMed Inc   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014159570     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. Lindgren S, Janzon L. Dysphagia: Prevalence of swallowing complaints and clinical findings. Medical Clinics of North America, 1993; 77:3-5.
2. Andersen O, Zweidorff OK, Hjelde T, Rodland EA. Problems when swallowing tablets. Tidsskr Nor Laegeforen, 1995; 115 (8):947-949.
3. Yamanouchi Pharmaceutical Co. Press release: Open Yamanouchi Shaklee Pharma Research Center at Stanford Research Park, November 24,1997.
4. Mizumoto T, Masuda Y, Fukui M. Intrabuccally dissolving compressed molding and production process thereof. U.S. Patent 5,576,014.
5. Mizumoto T, Masuda Y, Nyshadham J, Fukui M. Intrabuccally dissolving compressed molding and production process thereof. 1998, U.S. Patent application filed.
6. JP disintegration test, The Japanese Pharmacopoeia page 32, 13th edition, Japan:The Society of Japanese Pharmacopoeia, 1996.
7. Yamanouchi Quarterly Newsletter Nucleus, Autumn 46, page 1-2, 1998.
8. Company press release: Yamanouchi Shaklee Pharma has entered into a Feasibility and Option agreement with the Glaxo Wellcome Group. Shaklee, May 1998.
9. Company press release: Yamanouchi Shaklee Pharma has entered into an agreement with Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Shaklee, June 1998.
10. Company press release: Yamanouchi Shaklee Pharma and Warner-Lambert Company enter WOWTAB® commercialization phase. Shaklee, July 1998.
11. Virley P, Yarwood RJ. Zydis: A novel fast dissolving dosage form. Chemist 1990; 61 (2) 36-37.
12. Gregory GK, Peach JM, Mayne JD. Articles for carrying chemicals. U.S. Patent 4,371,516.
13. Thompson AR, Yarwood RJ, Kearney P. Method for identifying freeze-dried dosage forms. U.S. Patent 5,457,895.
14. Kearney P, Wong SK. Methods for making freeze dried drug dosage forms. U.S. Patent 5,631,023.
15. Buxton IR, Feldman. Solid shaped particles. U.S. Patent 4,754,597.
16. Seager H. Drug delivery products and Zydis® fast dissolving dosage form presented at the British Pharmaceutical Conference, Scarborough, September 1997.
17. Yarwood R. Oral fast dissolving dosage form technologies presented at IBC symposium on drug delivery systems. San Francisco, July 17-18, 1997.
18. Physician’s Desk Reference (PDR), 1999, page 2825, 53d edition, Medical Economics Company, Des Moines, IA 1999.
19. Company press release: Pfizer R.P. Scherer Corp. had signed a deal to develop a faster-acting thin wafer form of Viagra® using Scherer’s Zydis® drug delivery system. Pfizer, August 1998.
20. Company press release: FDA approves Maxalt™ and Maxalt-Mlt™. Merck & Co., June 1998.
21. Wehling F, Schuehle S, Madamala N. Effervescent dosage forms with microparticles. U.S. Patent 5,178,878.
22. Wehling F, Schuehle S. Base coated acid particles and effervescent formulations incorporating same. U.S. Patent 5,503,846.
23. Cima Labs Inc. Form 10-K for Cima Labs Inc. filed on March 26, 1998.
24. Wehling F, Schuehle S, Madamala N. Magnesium carbonate and oil tableting aid and flavoring additive. U.S. Patent 5,401,513.
25. Wehling F, Schuehle S, Madamala N. Pediatric effervescent dosage. U.S. Patent 5,223,264
26. Khattar JA. The role of fast-dissolving dosage forms in improving patient compliance presented at the international conference on drug delivery technologies: Capitalize on the newest scientific and commercial opportunities. Princeton, NJ, July 13-14, 1998.
27. Company press release: Cima announces completion of clinical study on Zomig™ fast dissolving tablet. Cima Labs Inc., October 1998.
28. Company press release: Cima entered into a development and license option agreement with Schering-Plough. Cima Labs Inc., August 1997.
29. Myers GL, Battist GE, Fuisz RC. Delivery of controlled release systems. U.S. Patent 5,567,439.
30. Fuisz RC. Biodegradable controlled release flash melt-spun delivery system. U.S. Patent 5,518,730.
31. Cherukuri SR, Myers GL, Battist GE, Fuisz RC. Process for forming quickly dispersing comestible unit and production therefrom. U.S. Patent 5,587,172.
32. Myers GL, Battist GE, Fuisz RC. Process and apparatus for making rapidly dissolving dosage unit and production therefrom. U.S. Patent 5,622,719.
33. Fuisz RC. Ulcer prevention method using a melt-spun hydrogel. U.S. Patent 5, 622,717.
34. USP bulk density test, The U.S. Pharmacopoeia 23, page 1830, 23rd edition, United States Pharmacopoeia, Rockville, MD, 1995.
35. Myers M. A new era in morphological drug change presented at IBC symposium on drug delivery systems. San Francisco, July 17-18, 1997.
36. Klancke J. Dissolution testing of orally disintegrating tablets, Dissolution Technology, 10(2):6-8, May 2003.
37. Parakh SR and Gothoskar AV. A review of mouth dissolving tablet technologies, Pharmaceutical Technology, 92-100, November 2003.
38. Brown D. Orally disintegrating tablets-Taste over speed, Drug Delivery Technology, 3(6):58-61, September 2000.